Unseen Biometrics ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2020/3
2020
2021/3
2021
2022/3
2022
2023/3
2023
2024/3
Bankruptcy risk for industry  1.2% 1.2% 1.2% 1.2% 1.2%  
Bankruptcy risk  5.0% 1.5% 7.6% 11.9% 12.3%  
Credit score (0-100)  45 77 31 19 18  
Credit rating  BBB A BB BB BB  
Credit limit (kDKK)  0.0 15.3 0.0 -0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/3
2020
2021/3
2021
2022/3
2022
2023/3
2023
2024/3

Net sales  0 0 0 0 0  
Gross profit  -14.5 1,180 -319 -1,810 -1,529  
EBITDA  -14.5 1,180 -944 -3,753 -4,436  
EBIT  -14.5 1,180 -944 -3,753 -4,969  
Pre-tax profit (PTP)  -14.5 1,179.5 -948.0 -4,009.0 -5,440.0  
Net earnings  -13.6 990.8 -681.0 -4,009.0 -5,589.6  
Pre-tax profit without non-rec. items  -14.5 1,179 -948 -4,009 -5,440  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/3
2020
2021/3
2021
2022/3
2022
2023/3
2023
2024/3

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  126 1,867 1,186 381 742  
Interest-bearing liabilities  100 200 200 3,134 3,559  
Balance sheet total (assets)  259 2,551 2,528 6,476 8,277  

Net Debt  48.2 -494 126 2,137 866  
 
See the entire balance sheet

Volume 
2019
2020/3
2020
2021/3
2021
2022/3
2022
2023/3
2023
2024/3

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -14.5 1,180 -319 -1,810 -1,529  
Gross profit growth  0.0% 0.0% 0.0% -467.4% 15.5%  
Employees  2 4 6 8 8  
Employee growth %  0.0% 100.0% 50.0% 33.3% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  259 2,551 2,528 6,476 8,277  
Balance sheet change%  0.0% 886.5% -0.9% 156.2% 27.8%  
Added value  -14.5 1,179.6 -944.0 -3,753.0 -4,435.8  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  140 1,073 875 1,642 409  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -1.0 1.0 -1.0 -2.0 -3.0  

Profitability 
2019
2020/3
2020
2021/3
2021
2022/3
2022
2023/3
2023
2024/3
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 100.0% 295.9% 207.3% 324.9%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -5.6% 84.0% -37.2% -83.4% -67.2%  
ROI %  -5.6% 91.1% -48.3% -132.9% -105.5%  
ROE %  -10.8% 99.4% -44.6% -511.7% -995.5%  

Solidity 
2019
2020/3
2020
2021/3
2021
2022/3
2022
2023/3
2023
2024/3
Equity ratio %  48.9% 73.2% 46.9% 8.2% 13.1%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -333.3% -41.9% -13.3% -56.9% -19.5%  
Gearing %  79.1% 10.7% 16.9% 822.6% 479.6%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.1% 2.0% 15.4% 14.5%  

Liquidity 
2019
2020/3
2020
2021/3
2021
2022/3
2022
2023/3
2023
2024/3
Quick Ratio  0.9 3.1 0.4 4.3 9.6  
Current Ratio  0.9 3.1 0.4 1.1 1.2  
Cash and cash equivalent  51.8 693.7 74.0 997.0 2,692.4  

Capital use efficiency 
2019
2020/3
2020
2021/3
2021
2022/3
2022
2023/3
2023
2024/3
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -7.2 890.3 -739.0 268.0 586.1  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/3
2020
2021/3
2021
2022/3
2022
2023/3
2023
2024/3
Net sales / employee  0 0 0 0 0  
Added value / employee  -7 295 -157 -469 -554  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  -7 295 -157 -469 -554  
EBIT / employee  -7 295 -157 -469 -621  
Net earnings / employee  -7 248 -114 -501 -699